EUVIMEDEUVIMED entdecken
Crossref

4337 SKELETAL MUSCLE MASS LOSS IN PATIENTS TREATED WITH SEMAGLUTIDE OR TIRZEPATIDE FOR WEIGHT REGAIN OR INSUFFICIENT WEIGHT LOSS POST BARIATRIC SURGERY

Surgery for Obesity and Related Diseases · 2026-04 · 22 (4) · S65-S66

DOI: 10.1016/j.soard.2026.02.217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgery for Obesity and Related Diseases, 2026-04.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). 4337 SKELETAL MUSCLE MASS LOSS IN PATIENTS TREATED WITH SEMAGLUTIDE OR TIRZEPATIDE FOR WEIGHT REGAIN OR INSUFFICIENT WEIGHT LOSS POST BARIATRIC SURGERY. Surgery for Obesity and Related Diseases, 22(4), S65-S66. https://doi.org/10.1016/j.soard.2026.02.217

Vancouver

4337 SKELETAL MUSCLE MASS LOSS IN PATIENTS TREATED WITH SEMAGLUTIDE OR TIRZEPATIDE FOR WEIGHT REGAIN OR INSUFFICIENT WEIGHT LOSS POST BARIATRIC SURGERY. Surgery for Obesity and Related Diseases. 2026;22(4):S65-S66. doi:10.1016/j.soard.2026.02.217

BibTeX
@article{euvimed2026,
  title = {4337 SKELETAL MUSCLE MASS LOSS IN PATIENTS TREATED WITH SEMAGLUTIDE OR TIRZEPATIDE FOR WEIGHT REGAIN OR INSUFFICIENT WEIGHT LOSS POST BARIATRIC SURGERY},
  journal = {Surgery for Obesity and Related Diseases},
  year = {2026},
  volume = {22},
  number = {4},
  pages = {S65--S66},
  doi = {10.1016/j.soard.2026.02.217}
}
Kostenlos starten →